We are keenly focused on how cells remodel their extracellular proteome in health and disease. To understand and disrupt human disease-associated signaling processes, we develop enabling technologies with protein & antibody engineering and site-directed small molecule approaches.
![](/sites/pharm.ucsf.edu/files/styles/original_cropped/public/wells/media-browser/offsite_2024_1.jpg?itok=A9OYeE9F)